Carlos Fernández Teruel

First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors

María Elena Elez, Josep Tabernero, David Geary et al. · Clinical Cancer Research · 2014 · 88 citations

A novel approach to determining physicochemical and absorption properties of 6-fluoroquinolone derivatives: experimental assessment

Miguel Ángel Cabrera‐Pérez, Humberto González‐Díaz, Carlos Fernández Teruel et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2002 · 48 citations

Medicinal Chemistry, Chemical Measurement, Engineering +13

Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer

Andrés Poveda, J.M. del Campo, Isabelle Ray‐Coquard et al. · Annals of Oncology · 2017 · 46 citations · Full text

Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors

Luis Paz‐Ares, Martin Förster, Valentina Boni et al. · Investigational New Drugs · 2016 · 24 citations · Full text

Medicine, Pharmacology, Pharmacokinetic Study +7

A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer

Neal D. Shore, Begoña Mellado, Satish K. Shah et al. · Clinical Genitourinary Cancer · 2022 · 22 citations · Full text